Society of Hematologic Oncology

Free SOHO Membership: www.sohoonline.org

 

Lymphoma
09:26

Society of Hematologic Oncology Eighth Annual Meeting (SOHO 2020)

2020 SOHO Update on MZL: Epidemiology and Outcomes in a Mexican Center

FEATURING Rosana Córdova
  • 9 views
  • December 15, 2020
25:00

Society of Hematologic Oncology Eighth Annual Meeting (SOHO 2020)

2020 SOHO Update on MZL: Genetic Subtype Specific Entities, Antibiotic Efficacy, Immunochemotherapy, BTK& PI3K Inhibitors

FEATURING Emanuele Zucca
  • 198 views
  • December 15, 2020
  • 1
14:51

Society of Hematologic Oncology Eighth Annual Meeting (SOHO 2020)

2020 SOHO Update on Relapsed FL: Salvage Bendamustine in Rituximab Refractory Pts, PI3K Inhibitors, Lenalidomide + Rituximab, EZH2i Tazemetostat, Autologous SCT

FEATURING Nathan H. Fowler
  • 87 views
  • December 15, 2020
08:38

Society of Hematologic Oncology Eighth Annual Meeting (SOHO 2020)

2020 SOHO MAVORIC Update on R/R CTCL: What Is the Impact of Concomitant Steroids on Mogamulizumab Efficacy?

FEATURING Larisa Geskin
  • 154 views
  • December 15, 2020
  • 1
15:22

Society of Hematologic Oncology Eighth Annual Meeting (SOHO 2020)

2020 SOHO Update on R/R PTCL: Is There a Single Paradigm Overall? Can Some Standard Treatments Be Curative? What Are the New Agents / Strategies?

FEATURING Steven Horwitz
  • 105 views
  • December 14, 2020
13:26

Society of Hematologic Oncology Eighth Annual Meeting (SOHO 2020)

2020 SOHO Update on Newly Diagnosed PTCL: Should All Pts Undergo Upfront Consolidative Auto-SCT? Is CHP-BV the New SoC in All CD30+ PTCLs? Is Consolidative Auto-SCT Still Needed Post CHP-BV?

FEATURING Kerry Savage
  • 200 views
  • December 14, 2020
08:07

Society of Hematologic Oncology Eighth Annual Meeting (SOHO 2020)

2020 SOHO Update on 1L Advanced cHL: What Are the Outcomes in HIV-cHL vs. Non-HIV-cHL?

FEATURING Juan José Del Moral
  • 11 views
  • December 14, 2020
21:36

Society of Hematologic Oncology Eighth Annual Meeting (SOHO 2020)

2020 SOHO Highlights on Newly Diagnosed HL: Is ABVD Chemo Regimen Beneficial for PFS in Early Stage Disease? Can A+AVD Resolve Peripheral Neuropathy in Advanced Stage Disease?

FEATURING David Straus
  • 118 views
  • November 9, 2020
22:32

Society of Hematologic Oncology Eighth Annual Meeting (SOHO 2020)

2020 SOHO Updates on IO for T-ALL/T-NHL: Is UCART7 Effective at Killing Cancer Cells? How Does NT-I7 Affect CAR-T in Vitro/in Vivo?

FEATURING John DiPersio
  • 7 views
  • October 30, 2020
15:55

Society of Hematologic Oncology Eighth Annual Meeting (SOHO 2020)

R/R HL Updates: What Are Frontline Therapeutic Choices and How Can We Integrate Novel Agents? What Combinations Can Help Overcome Resistance and PD-1 Blockade?

FEATURING Alex Herrera
  • 139 views
  • October 30, 2020
07:11

Society of Hematologic Oncology Eighth Annual Meeting (SOHO 2020)

2020 SOHO Update on PB-DLBCL: Does the Role of RT Differ Between Stages?

FEATURING Shengling Ma
  • 14 views
  • October 30, 2020
18:48

Society of Hematologic Oncology Eighth Annual Meeting (SOHO 2020)

2020 SOHO Highlights on CARs: How Does the Ideal Next-Gen CAR T-Cell Look Like? What Is the Safety Profile of Novel Armored Cells?

FEATURING Renier Brentjens
  • 128 views
  • October 30, 2020
09:59

Society of Hematologic Oncology Eighth Annual Meeting (SOHO 2020)

2020 SOHO Updates on R/R cHL: Can We Improve Chemo With ADCs and CPI? Is Toxicity Excessive Compared to Standard Regimens?

FEATURING David Straus
  • 49 views
  • October 30, 2020
11:13

Society of Hematologic Oncology Eighth Annual Meeting (SOHO 2020)

2020 SOHO Update on DLBCL: CAR-T vs. autoHCT for Early Relapsed Disease and PET+ Sensitive Pts? CAR-T vs alloHCT in Post-Auto Relapse? What Cellular Therapies Will Be Available in the Next 5 yrs?

FEATURING Sergio Giralt
  • 20 views
  • October 27, 2020
10:17

Society of Hematologic Oncology Eighth Annual Meeting (SOHO 2020)

2020 SOHO Update on DLBCL: Can Genomics Improve Patient Clinical Outcomes?

FEATURING Sandeep Dave
  • 112 views
  • October 27, 2020
  • 1
10:21

Society of Hematologic Oncology Eighth Annual Meeting (SOHO 2020)

2020 SOHO Update on Follicular Lymphoma: Is Watch and Wait Still Appropriate for Asymptomatic Advanced Stage Disease in the COVID-19 Era? What Is the New SoC 1L Maintenance?

FEATURING Robert Marcus
  • 186 views
  • October 27, 2020
09:54

Society of Hematologic Oncology Eighth Annual Meeting (SOHO 2020)

2020 SOHO Next Steps in T-Cell Lymphoma: Is Personalized Therapy Possible in PTCL? How Can We Efficiently Study Combinations? Can Genomic Studies Guide Rationale Therapeutics?

FEATURING Kerry Savage
  • 165 views
  • October 27, 2020
  • 1
09:51

Society of Hematologic Oncology Eighth Annual Meeting (SOHO 2020)

2020 SOHO Next Steps in MCL: Is ASCT Appropriate for All Patients? Are We Ready for Personalized Medicine Based on Molecular Assessment and Prognostic Markers? What Is the Ultimate Role of CAR-T?

FEATURING Jonathon Cohen
  • 48 views
  • October 27, 2020
21:24

Society of Hematologic Oncology Eighth Annual Meeting (SOHO 2020)

2020 SOHO Highlights on Genomics in DLBCL: How Does Gene Expression Profiling Work? What Is Genetic Survival Analysis?

FEATURING Sandeep Dave
  • 5 views
  • October 23, 2020
12:34

Society of Hematologic Oncology Eighth Annual Meeting (SOHO 2020)

2020 SOHO Updates on DLBCL: Can We Use CRISPR and Drug Screening to Identify Novel Single Agent Therapies and Biomarkers? Is JAKi Combination a Good Strategy to Overcome Single Agent Therapy Resistance?

FEATURING Sandeep Dave
  • 4 views
  • October 23, 2020
15:26

Society of Hematologic Oncology Eighth Annual Meeting (SOHO 2020)

2020 SOHO Updates on DLBCL: Can We Go Beyond R-CHOP by Incorporating Genomics in the Clinical Workup of Patients and Clinical Trials?

FEATURING Sandeep Dave
  • 12 views
  • October 23, 2020
15:25

Society of Hematologic Oncology Eighth Annual Meeting (SOHO 2020)

2020 SOHO Highlights on CAR-T in Aggressive B-NHL: Are There Differences in OS and ORR in Pivotal CD19 Trials? How to Properly Select Patients? What Are the Potential Causes of CAR-T Failure?

FEATURING Peter Riedell
  • 17 views
  • October 22, 2020
13:41

Society of Hematologic Oncology Eighth Annual Meeting (SOHO 2020)

2020 SOHO Updates on Frontline MCL: How Do Guidelines Differ Between Countries and Institutions? Are the Chemo-Free Approaches the Future SoC?

FEATURING Steven Le Gouill
  • 90 views
  • October 20, 2020
14:41

Society of Hematologic Oncology Eighth Annual Meeting (SOHO 2020)

2020 SOHO Highlights on R/R MCL: What Are the Long Term Outcomes With BTK-Inhibitors? How Does the FDA-Approved KTE-X19 Affect PFS/OS?

FEATURING Jonathon Cohen
  • 115 views
  • October 19, 2020
15:00

Society of Hematologic Oncology Eighth Annual Meeting (SOHO 2020)

2020 SOHO Updates on R/R DLBCL: Is There Still a Role for AutoHCT? Is CAR-T Beneficial in B-nHL? How Does FDA-Approved Selinexor Affect the Duration of Response & OS?

FEATURING Sonali Smith
  • 30 views
  • October 19, 2020
18:06

Society of Hematologic Oncology Eighth Annual Meeting (SOHO 2020)

2020 SOHO Updates on IO in Aggressive B-nHL: What Is the ORR With Mosunetuzumab/Odronextamab in R/R Disease? How Does Dosing of Glofitamab Affect Anti-Tumor Activity?

FEATURING Martin Hutchings
  • 5 views
  • October 19, 2020
17:13

Society of Hematologic Oncology Eighth Annual Meeting (SOHO 2020)

2020 SOHO Update on Waldenstrom Macroglobulinemia: What Are the Effects of Rituximab/Bendamustine on OS? How to Treat Newly Diagnosed Disease?

FEATURING Morie Gertz
  • 20 views
  • October 19, 2020
06:16

Society of Hematologic Oncology Eighth Annual Meeting (SOHO 2020)

2020 SOHO Update on Frontline MCL: How Effective Is Ibrutinib+Venetoclax Combo in Older/TP53-Mutated Patients?

FEATURING Michael Wang
  • 288 views
  • October 15, 2020
  • 2